U.S. study finds racial, gender differences in surgical treatment of dermatofibrosarcoma protuberansOctober 4, 2021Diversity in MedicineMixed TopicsCancerOncologyDermatology
FDA approval for tisotumab vedotin in advanced cervical cancerSeptember 30, 2021OncologyWomen's HealthCancer
Study supports chemotherapy with immunotherapy for some never-smokers with lung cancerSeptember 28, 2021Lung CancerOncologyCancer
Duty to Assist: Assisting Veterans with Exposures to Hazardous MaterialsSeptember 27, 2021OncologyCancer
FDA approves first oral drug for NSCLC with EGFR Exon 20 insertionSeptember 20, 2021Lung CancerOncologyCancer
Immunotherapy for cancer patients with poor PS needs a rethinkSeptember 20, 2021Breast CancerOncologyLung CancerGenitourinary CancerMelanomaCancer
Antibiotic use and colon cancer: More evidence of linkSeptember 14, 2021Infectious DiseasesOncologyMixed TopicsCancer
Pandemic strategies to boost trial enrollment should staySeptember 13, 2021Lung CancerCOVID-19 UpdatesOncologyCancer
Old saying about prostate cancer not true when it’s metastaticSeptember 7, 2021Genitourinary CancerProstate CancerOncologyCancer
‘Dawn of a new era’ in the treatment of renal cell carcinomaSeptember 7, 2021Genitourinary CancerOncologyCancer
NCCN recommends third COVID-19 dose for patients with cancerSeptember 7, 2021COVID-19 UpdatesOncologyCancer
Although inconclusive, CV safety study of cancer therapy attracts attentionAugust 30, 2021StrokeCardiologyOncologyGenitourinary CancerCancer
Pandemic-related drops in breast cancer screening hit hardest among medically underservedAugust 30, 2021Breast CancerOncologyWomen's HealthCancer
Health-Related Quality of Life and Toxicity After Definitive High-Dose-Rate Brachytherapy Among Veterans With Prostate CancerAugust 18, 2021Prostate CancerCancerOncology
